PedAM
Pediatric Disease Annotations & Medicines
| Disease | liver disease |
| Phenotype | |hypertension |
| Sentences | 63 |
| PubMedID- 25680670 | Background & aims: risk factors for cardiovascular disease, such as obesity and hypertension, have been associated with nonalcoholic fatty liver disease. |
| PubMedID- 24820314 | Hps is a significant complication of portal hypertension in children with chronic liver disease and is an established indication for lt. |
| PubMedID- 24771990 | Chronic liver disease, especially with associated portal hypertension, has also been linked to the presence of gi angioectasias and, as reported by some authors, they could be reversed after transjugular intrahepatic portosystemic shunt [34, 38, 39]. |
| PubMedID- 21978390 | Markers of impaired intestinal permeability are elevated in portal hypertension, particularly with severe liver disease, and in viral and alcoholic cirrhosis [11,32]. |
| PubMedID- 20002632 | The incidence of porto-pulmonary hypertension (pphn) in patients with end stage liver disease is 8.5%. |
| PubMedID- 25834796 | The former involved graft size, quality, and flow as graft-related factors, and portal hypertension and the severity of the liver disease as recipient-related factors. |
| PubMedID- 20714839 | Background/purpose: the diagnosis of porto-pulmonary hypertension (pphn) in patients with end-stage liver disease at the time of surgery is not an uncommon occurrence. |
| PubMedID- 25590846 | Furthermore, to exclude the effect of cardiovascular factors, patients with confirmed cardiovascular diseases or taking any agents affecting qtc interval before the establishment of achblf were excluded, such as β-blockers, even if it is recommended in patients with portal hypertension associated with chronic liver diseases. |
| PubMedID- 24393789 | Mortality is closely related to liver dysfunction or portal hypertension complications due to underlying liver disease, portal thrombosis and/or massive tumour involvement[3]. |
| PubMedID- 22986694 | Purpose: cystic-fibrosis-associated liver disease (cfld) may lead to portal hypertension (pht) and cirrhosis. |
| PubMedID- 21389799 | Portopulmonary hypertension is a complication of chronic liver disease, which has significant effects on survival and prognosis. |
| PubMedID- 25667596 | Cirrhosis is scarring of the liver and also is the final stage of many chronic liver diseases, leading to portal hypertension and end-stage liver disease [1]. |
| PubMedID- 25568485 | However, ultrasound examination of the abdomen revealed parenchymal liver disease with portal hypertension and ascites. |
Page: 1 2